M M Mamdani1, K Tu, L Jaakkimainen
1Institute for Clinical Evaluative Sciences, Toronto, Ont.
A new policy encouraging histamine-type 2 receptor antagonist (H2RA) use before proton pump inhibitor (PPI) therapy showed a modest 9% increase in compliance. Careful consideration of costs and benefits is recommended for future interventions.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: